Activation of caspase-3 appears to be a key event in the execution of the apoptotic cascade in numerous central nervous system diseases, such as Alzheimer’s disease and Down’s syndrome. This evidence concerns the gene CASP3 and early-onset autosomal dominant Alzheimer disease.